Profil
Paul Chinn is Chief Scientific Officer and Vice President of Research and Development for Aduro BioTech, Inc. Prior to joining Aduro BioTech, he worked for Biogen-IDEC Pharmaceuticals.
Previously, he was a Scientist of Synbiotics Corp.
Dr. Chinn has 20 years of experience in research and pre-clinical development of biotherapeutic proteins.
He received an undergraduate degree in Biochemistry from the University of California, Los Angeles and a PhD in Chemistry from the University of California, San Diego.
Anciens postes connus de Paul Chinn
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | - |
Synbiotics LLC
Synbiotics LLC Medical SpecialtiesHealth Technology Develops monoclonal antibody-based diagnostic and biological products | Directeur Technique/Scientifique/R&D | - |
| CHINOOK THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Paul Chinn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Synbiotics LLC
Synbiotics LLC Medical SpecialtiesHealth Technology Develops monoclonal antibody-based diagnostic and biological products | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















